Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA.
| Autor: | Grewal US; Division of Hematology, Oncology, Bone and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. udhayvir-grewal@uiowa.edu., Thakre A; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Endocrine [Endocrine] 2024 Dec; Vol. 86 (3), pp. 1192-1193. Date of Electronic Publication: 2024 Jun 07. |
| DOI: | 10.1007/s12020-024-03915-z |
| Abstrakt: | Competing Interests: Compliance with ethical standards Conflict of interest The authors declare no competing interests. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink